From: Validation of brain parenchyma sonography as a marker of neurodegeneration in multiple sclerosis
MS group (n = 48) | Control group (n = 57) | p- value | ||||
---|---|---|---|---|---|---|
Range | Mean ± SD | Range | Mean ± SD | |||
Ventricular diameter (cm) | 3rd ventricle | 0.12–0.76 | 0.34 ± 0.15 | 0.07–0.45 | 0.2 ± 0.08 | < 0.001* |
Rt. FH | 0.3–0.87 | 0.49 ± 0.14 | 0.12–0.85 | 0.30 ± 0.13 | < 0.001* | |
Lt. FH | 0.23–0.92 | 0.45 ± 0.15 | 0.02–0.54 | 0.28 ± 0.1 | < 0.001* | |
SA of DGM (cm2) | Rt. Th | 2.11–7.78 | 4.18 ± 1.1 | 2.59–6.88 | 4.43 ± 0.97 | 0.22 |
Lt. Th | 1.87–7.8 | 4.29 ± 1.27 | 2.48–8.55 | 4.67 ± 1.24 | 0.12 | |
Rt. SN | 0.02–0.95 | 0.19 ± 0.13 | 0.03–0.26 | 0.15 ± 0.05 | 0.04* | |
Lt. SN | 0.05–0.34 | 0.17 ± 0.07 | 0.05–0.26 | 0.15 ± 0.06 | 0.17 | |
Rt. RN | 0.04–0.46 | 0.08 ± 0.07 | 0.02–0.17 | 0.05 ± 0.03 | 0.01* | |
Lt. RN | 0.02–0.6 | 0.09 ± 0.08 | 0.01–0.16 | 0.06 ± 0.03 | 0.04* |